Patents Assigned to CLASSEN IMMUNOTHERAPIES
-
Publication number: 20130311466Abstract: The invention comprises systems, methods and a computerized, data management device for creating and using data relating to a medical or non-medical product or device to enhance the safety of the product or device. A vast amount of data regarding adverse events associated with a particular product or device is analyzed to identify new essential adverse events associated with the product or device. At least one database anew essential adverse event information is created and utilized, and new characteristics of or uses for the product or device related to the new essential adverse event information are determined. Adverse event information is gathered for a large number of population sub-groups. The system may also be programmed to incorporate the information into intellectual property and contract documents.Type: ApplicationFiled: July 25, 2013Publication date: November 21, 2013Applicant: CLASSEN, IMMUNOTHERAPIES, INC.Inventor: John Barthelow CLASSEN
-
Patent number: 8515932Abstract: The invention comprises systems, methods and a computerized data management device for creating and using data relating to a medical or non-medical product or device to enhance the safety of the product or device. A vast amount of data regarding adverse events associated with a particular product or device is analyzed to identify new essential adverse events associated with the product or device. At least one database of new essential adverse event information is created and utilized, and new characteristics of or uses for the product or device related to the new essential adverse event information are determined. Adverse event information is gathered for a large number of population sub-groups. The system may also be programmed to incorporate the information into intellectual property and contract documents.Type: GrantFiled: June 9, 2011Date of Patent: August 20, 2013Assignee: Classen Immunotherapies, Inc.Inventor: John Barthelow Classen
-
Publication number: 20110238585Abstract: The invention comprises systems, methods and a computerized data management device for creating and using data relating to a medical or non-medical product or device to enhance the safety of the product or device. A vast amount of data regarding adverse events associated with a particular product or device is analyzed to identify new essential adverse events associated with the product or device. At least one database of new essential adverse event information is created and utilized, and new characteristics of or uses for the product or device related to the new essential adverse event information are determined. Adverse event information is gathered for a large number of population sub-groups. The system may also be programmed to incorporate the information into intellectual property and contract documents.Type: ApplicationFiled: June 9, 2011Publication date: September 29, 2011Applicant: CLASSEN IMMUNOTHERAPIESInventor: John Barthelow CLASSEN
-
Patent number: 7984069Abstract: The invention comprises systems, methods and a computerized data management device for creating and using data relating to a medical or non-medical product or device to enhance the safety of the product or device. A vast amount of data regarding adverse events associated with a particular product or device is analyzed to identify new essential adverse events associated with the product or device. At least one database of new essential adverse event information is created and utilized, and new characteristics of or uses for the product or device related to the new essential adverse event information are determined. Adverse event information is gathered for a large number of population sub-groups. The system may also be programmed to incorporate the information into intellectual property and contract documents.Type: GrantFiled: February 21, 2002Date of Patent: July 19, 2011Assignee: Classen Immunotherapies, Inc.Inventor: John Barthelow Classen
-
Patent number: 7653639Abstract: The invention comprises systems, methods and a computerized data management device for creating and using data relating to a medical or non-medical product or device to enhance the safety of the product or device. A vast amount of data regarding adverse events associated with a particular product or device is analyzed to identify new essential adverse events associated with the product or device. At least one database of new essential adverse event information is created and utilized, and new characteristics of or uses for the product or device related to the new essential adverse event information are determined. Adverse event information is gathered for a large number of population sub-groups. The system may also be programmed to incorporate the information into intellectual property and contract documents.Type: GrantFiled: May 15, 2006Date of Patent: January 26, 2010Assignee: Classen Immunotherapies, Inc.Inventor: John Barthelow Classen
-
Publication number: 20080172247Abstract: A method of safer immunization against infectious diseases by considering the potential recipients family history or other risk factors for a chronic immune mediated disorders, especially type 1 diabetes prior to immunizing the recipient. The method may include screening potential recipients of a vaccine and selectivity avoiding immunizing or administering a lower risk immunization schedule to those at increased risk for the chronic immune mediated disorder. The resulting method will lower the risk of the recipient in developing the immune mediated disorder.Type: ApplicationFiled: April 6, 2005Publication date: July 17, 2008Applicant: CLASSEN IMMUNOTHERAPIESInventor: John Barthelow Classen
-
Patent number: 7008790Abstract: A method of immunization, and compositions therefor, are provided for substantially preventing or reducing the symptoms of at least one infectious disease and at least one chronic immune mediated disorder. An immunogenic challenge which supplements the normal childhood immunization schedule can help ensure the proper maturation of the immune system and prevent the development of chronic immune mediated disorders, such as immune-mediated diabetes or SLE.Type: GrantFiled: September 12, 2000Date of Patent: March 7, 2006Assignee: Classen Immunotherapies, Inc.Inventor: John Barthelow Classen
-
Patent number: 6638739Abstract: A method of immunization, and compositions therefor, are provided for substantially preventing or reducing the symptoms of at least one infectious disease and at least one chronic immune mediated disorder. An immunogenic challenge which supplements the normal childhood immunization schedule can help ensure the proper maturation of the immune system and prevent the development of chronic immune mediated disorders, such as immune-mediated diabetes or SLE.Type: GrantFiled: April 18, 2002Date of Patent: October 28, 2003Assignee: Classen Immunotherapies, Inc.Inventor: John Barthelow Classen
-
Patent number: 6584472Abstract: The mechanism comprises systems, methods and computerized data management device for creating and using data relating to a medical or non-medical product or device to enhance the safety of the product or device. Vast amounts of data is received regarding adverse events associated with a particular product or device, which data is analyzed in light of known adverse events associated with the product or device. At least one proprietary database of newly discovered adverse event information is created and utilized, and new characteristics of or uses for the product or device are determined. Adverse event information is gathered for a large number of population sub-groups. The system may also be programmed to incorporate the information into intellectual property and contract documents.Type: GrantFiled: March 12, 2001Date of Patent: June 24, 2003Assignee: Classen Immunotherapies, Inc.Inventor: John Barthelow Classen
-
Publication number: 20020083080Abstract: The invention comprises systems, methods and a computerized data management device for creating and using data relating to a medical or non-medical product or device to enhance the safety of the product or device. A vast amount of data regarding adverse events associated with a particular product or device is analyzed to identify new essential adverse events associated with the product or device. At least one database of new essential adverse event information is created and utilized, and new characteristics of or uses for the product or device related to the new essential adverse event information are determined. Adverse event information is gathered for a large number of population sub-groups. The system may also be programmed to incorporate the information into intellectual property and contract documents.Type: ApplicationFiled: February 21, 2002Publication date: June 27, 2002Applicant: CLASSEN IMMUNOTHERAPIESInventor: John Barthelow Classen
-
Patent number: 6219674Abstract: Systems and methods for creating and using product data to enhance the safety of a medical or non-medical products. The systems receive vast amounts of data regarding adverse events associated with a particular product and analyze the data in light of already known adverse events associated with the product. The system develops at least one proprietary database of newly discovered adverse event information and new uses for the product and may catalog adverse event information for a large number of population sub-groups. The system may also be programmed to incorporate the information into intellectual property and contract documents. Manufacturers can include the information in consumer product information which they provide to consumers or, in the case of certain medical products, prescribers of the medical products.Type: GrantFiled: November 24, 1999Date of Patent: April 17, 2001Assignee: Classen Immunotherapies, Inc.Inventor: John Barthelow Classen
-
Patent number: 5728385Abstract: A method of immunization, and compositions therefor, are provided for substantially preventing or reducing the symptoms of at least one infectious disease and at least one chronic immune mediated disorder. An immunogenic challenge which supplements the normal childhood immunization schedule can help ensure the proper maturation of the immune system and prevent the development of chronic immune mediated disorders.Type: GrantFiled: August 12, 1993Date of Patent: March 17, 1998Assignee: Classen Immunotherapies, Inc.Inventor: John Barthelow Classen
-
Patent number: 5723283Abstract: A method of immunization, and compositions therefor, are provided for substantially preventing or reducing the symptoms of at least one infectious disease and at least one chronic immune mediated disorder. An immunogenic challenge which supplements the normal childhood immunization schedule can help ensure the proper maturation of the immune system and prevent the development of chronic immune mediated disorders.Type: GrantFiled: May 31, 1995Date of Patent: March 3, 1998Assignee: Classen Immunotherapies, Inc.Inventor: John Barthelow Classen